Literature DB >> 24838066

Traumatic injury elicits JNK-mediated human astrocyte retraction in vitro.

C Augustine1, G Cepinskas2, D D Fraser3.   

Abstract

Brain injury causes dysfunction of the blood-brain barrier (BBB). The BBB is comprised of perivascular astrocytes whose end-feet ensheath brain microvascular endothelial cells. We investigated trauma-induced morphological changes of human astrocytes (HA) and human cerebral microvascular endothelial cells (hCMEC/D3) in vitro, including the potential role of mitogen-activated protein kinase (MAPK) signal-transduction pathways. HA or hCMEC/D3 were grown on flexible culture membranes and subjected to single traumatic injury normalized to 20%, 30% or 55% membrane deformation. Cells were assayed for morphological changes (i.e. retraction) and MAPK phosphorylation and/or expression (c-Jun NH2-terminal kinase (JNK)1/2, extracellular signal-regulated kinase (ERK)1/2, and p38). HA retraction was rapidly elicited with a single traumatic injury (55% membrane deformation; p<0.01). Morphological recovery of HA was observed within 2h (p<0.05). Traumatic injuries increased phospho-JNK1/2 (p<0.05) in HA, indicating MAPK activation. Pre-treatment of HA with structurally distinct JNK inhibitors (25μM), either SP600125 or SU3327, reduced JNK phosphorylation (p<0.05) and trauma-induced HA retraction (P<0.05). In contrast to HA, traumatic injury failed to induce either morphological changes or MAPK activation in hCMEC/D3. In summary, traumatic injury induces JNK-mediated HA retraction in vitro, while sparing morphological changes in cerebral microvascular endothelial cells. Astrocyte retraction from microvascular endothelial cells in vivo may occur after brain trauma, resulting in cellular uncoupling and BBB dysfunction. JNK may represent a potential therapeutic target for traumatic brain injuries.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  astrocytes; blood–brain barrier; brain microvascular endothelial cells; human; trauma

Mesh:

Substances:

Year:  2014        PMID: 24838066     DOI: 10.1016/j.neuroscience.2014.05.009

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Chronic traumatic encephalopathy: A paradigm in search of evidence?

Authors:  Rudy J Castellani
Journal:  Lab Invest       Date:  2015-04-13       Impact factor: 5.662

Review 2.  JNK signaling as a target for anticancer therapy.

Authors:  Kamal S Abdelrahman; Heba A Hassan; Salah A Abdel-Aziz; Adel A Marzouk; Atsushi Narumi; Hiroyuki Konno; Mohamed Abdel-Aziz
Journal:  Pharmacol Rep       Date:  2021-03-12       Impact factor: 3.024

Review 3.  New experimental models of the blood-brain barrier for CNS drug discovery.

Authors:  Mohammad A Kaisar; Ravi K Sajja; Shikha Prasad; Vinay V Abhyankar; Taylor Liles; Luca Cucullo
Journal:  Expert Opin Drug Discov       Date:  2016-11-07       Impact factor: 6.098

4.  Assessment of the Effects of Stretch-Injury on Primary Rat Microglia.

Authors:  Mike Shaughness; Kimberly Byrnes
Journal:  Mol Neurobiol       Date:  2021-03-24       Impact factor: 5.590

Review 5.  Pathophysiological Significance of WDR62 and JNK Signaling in Human Diseases.

Authors:  Yiqiang Zhi; Xiaokun Zhou; Jurui Yu; Ling Yuan; Hongsheng Zhang; Dominic C H Ng; Zhiheng Xu; Dan Xu
Journal:  Front Cell Dev Biol       Date:  2021-04-16

Review 6.  Study of BBB Dysregulation in Neuropathogenicity Using Integrative Human Model of Blood-Brain Barrier.

Authors:  Coraly Simöes Da Gama; Mélanie Morin-Brureau
Journal:  Front Cell Neurosci       Date:  2022-06-10       Impact factor: 6.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.